Search



Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Gliffy Diagram
size800
displayNameMedicinal Product Form
nameMedicinal Product Form
pagePin1

Figure 2622: Medicinal Product Form (containing) stated template view

Example: single active ingredient product, oral dose form: stated view followed by the inferred view that shows the two proximal parent concepts associated with the product: 


Figure 2723: Medicinal Product Form (containing) example stated view

Figure 2824: Medicinal Product Form (containing) example inferred view

...

Gliffy Diagram
size800
displayNameMedicinal Product Form
nameMedicinal Product Form (only)
pagePin1

Figure 2925: Medicinal Product Form (only) stated template view

Example: single active ingredient product, oral dose form: stated view followed by the inferred view that shows the proximal parent concepts associated with the product: 


Figure 3026: Medicinal Product Form (only) example stated view

Figure 3127: Medicinal Product Form (only) example inferred view

...

For concepts that have two or more active ingredient substances that are modifications of the same base substance, and where MP precisely concepts are required, and for single ingredient product concepts where the active substance is an ingredient in these multiple modification multi-ingredient products, the following extra ingredient count attribute will be required n order to support correct relationships generated by the MRCM:

Range

  • INT (integer)

Cardinality

  • 1..1

For concepts that have two or more active ingredient substances that are modifications of the same base active ingredient substance (i.e. parent ingredient substance) and where one is a further modification of the other (for example, a multi-ingredient product containing both dexamethasone phosphate and dexamethasone sodium phosphate, where the dexamethasone phosphate is a modification of dexamethasone (base) and dexamethasone sodium phosphate is a further modification of the dexamethasone phosphate) and where MP precisely concepts are required, and for single ingredient product concepts where the active substance is an ingredient in these multiple modification multi-ingredient products, the following extra ingredient count attribute will be required n order to support correct relationships generated by the MRCM:

Range

  • INT (integer)

Cardinality

  • 1..1

As described in the MRCM rules, for practical and pragmatic reasons the additional ingredient count attributes have to be applied iteratively based on requirement. 

...